impact factor, citescore
logo
 

Full Papers

 

Oral health and oral quality of life in inactive patients with familial Mediterranean fever without amyloidosis


, , , , , , , , ,

 

CER5955
2013 Vol.31, N°3 ,Suppl.77
PI 0015, PF 0019
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 23557976 [PubMed]

Received: 04/09/2012
Accepted : 19/11/2012
In Press: 02/04/2013
Published: 09/09/2013

Abstract

OBJECTIVES:
The aim of this study was to investigate oral and general health-related quality of life (QoL) in patients with familial Mediterranean fever (FMF) disease.
METHODS:
In this cross-sectional study, 45 patients with FMF, 50 age- and sex-matched healthy controls (HC), and 50 patients with Behçet`s disease (BD) as the disease control group were included. FMF disease activity was evaluated by using the FMF-severity score, as well as with erythrocyte sedimentation rate (ESR), and serum C-reactive protein and fibrinogen levels. Oral health-related QoL and general QoL were evaluated using oral health impact profile-14 (OHIP-14) and Medical Outcomes Short-Form Health Survey Questionnaire 36 (SF-36), respectively.
RESULTS:
Only the numbers of extracted teeth (4.13±4.72 vs. 1.55±3.6) and filled teeth (2.33±3.19 vs. 0.66±1.46) were significantly higher in FMF group compared to HC group (p=0.005 and p=0.013, respectively). OHIP-14 score was significantly higher in FMF and BD groups compared to HC group. In FMF patients, OHIP-14 score was positively correlated with the number of extracted teeth (r=0.38, p=0.010), while the number of carious teeth was positively correlated with ESR (r=0.43, p=0.003). When FMF patients were sub-classified according to disease severity, no significant difference was observed with respect to oral health status.
CONCLUSIONS:
In patients with FMF, some of the parameters of oral health status were found to be worse compared to HC group. Tooth loss appears to be to be a critical factor contributing to impaired oral QoL. In general, oral health status in FMF patients is better than in BD patients.

Rheumatology Article